Solanezumab shows potential efficacy for preventing disease progression in early-stage Alzheimer’s disease.
Browsing: Cognitive/neurodegenerative disorders
This article evaluates the recent evidence surrounding the possible interrelationship between Alzheimer’s disease and epilepsy and looks to its possible use in the clinic.
Pietro Gareri from The Regional Center for Neurogenetics at Lamezia Terme Hospital (Catanzaro, Italy) discusses the future of the use of antipsychotics to manage behavior in dementia patients.
New study highlights the potential efficacy of existing antimalarial drugs as a treatment for Parkinson’s.
David Vodušek presents an overview of a few of the main topics of discussion at the 1st Congress of the European Academy of Neurology.
Natural antioxidants can be easily overwhelmed by highly elevated levels of reactive oxyden species during disease or traumatic injury. This article discusses the need to develop synthetic antioxidant treatments that renormalize elevated levels of oxidative stress following injury.
A newly proposed mechanism of chromatin-dependent DNA damage response offers novel possibilities for neurodegenerative disease treatment and prevention.
Connections between the dorsolateral prefrontal cortex and posterior brain regions have been found to be weaker in MS patients, potentially due to a decline in white matter surrounding neurons.
A new survey carried out by the Alzheimer’s Society has indicated that throughout the UK the majority of doctors believe that the onus of care falls on the families of dementia patients.